RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Research & development

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 2024552+9.21%
Dec 31, 2023506+4.46%
Dec 31, 2022484-6.36%
Dec 31, 2021517+43.68%
Dec 31, 2020360+31.59%
Dec 31, 2019274+36.96%
Dec 31, 2018200+7.71%
Dec 31, 2017185+18.77%
Dec 31, 2016156+13.53%
Dec 31, 2015138+98.13%
Dec 31, 201469+54.91%
Dec 31, 201345+13.42%
Dec 31, 201240+28.47%
Dec 31, 201131

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)